Skip to main content
Erschienen in: Intensive Care Medicine 8/2006

01.08.2006 | Original

The prevalence and characteristics of anaemia at discharge home after intensive care

verfasst von: Timothy S. Walsh, Ezz-el-din Saleh, Robert J. Lee, D. Brian McClelland

Erschienen in: Intensive Care Medicine | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective

To document the prevalence of anaemia among ICU survivors at the time of discharge home and to document red cell morphology among anaemic patients.

Design and setting

Observational cohort study in a single-centre teaching hospital.

Patients and participants

Three cohorts of ICU admissions over a 3-year period managed with restrictive ICU transfusion practice. The study group comprised the 283 patients who survived and were discharged directly home from our hospital.

Measurements and results

The median time from ICU discharge to hospital discharge was 13 days (IQR 6–22, range 1–119). Using the last recorded Hb concentration 77.4% (95% CI 72.2–82.1) of patients were anaemic, 32.5% (27.3–38.2) had Hb less than 100 g/l, and 11.3% (8.1–15.5) had Hb less than 90 g/l at hospital discharge. Patients who spent longer in intensive care and in hospital after ICU discharge were more likely to be discharged home anaemic. The strongest predictor of discharge home with Hb less than 100 g/l was Hb at the time of ICU discharge. Multivariate regression analysis showed patient age, gender, APACHE II score, and ICU length of stay not to be independent predictors after including the ICU discharge Hb. Among anaemic patients 82% had normochromic normocytic red cell indices, but 12% had red cell hypochromasia and/or microcytosis, which may indicate iron deficiency.

Conclusions

Anaemia is highly prevalent among survivors of critical illness and persists until hospital discharge. Most patients have red cell morphology similar to “anaemia of chronic disease”.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417PubMedCrossRef Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417PubMedCrossRef
2.
Zurück zum Zitat Cortesi E, Gastcon P, Henry D, Littlewood T, Milroy R, Pronzato P, Reinhardt U, Shasha D, Thatcher N, Wilkinson P (2005) Standard of care for cancer-related anaemia: improving hemoglobin levels and quality of life. Oncology 68 [Suppl 1]:22–32PubMedCrossRef Cortesi E, Gastcon P, Henry D, Littlewood T, Milroy R, Pronzato P, Reinhardt U, Shasha D, Thatcher N, Wilkinson P (2005) Standard of care for cancer-related anaemia: improving hemoglobin levels and quality of life. Oncology 68 [Suppl 1]:22–32PubMedCrossRef
3.
Zurück zum Zitat Rao M, Pereira BJ (2005) Optimal anemia management reduces cardiovascular morbidity, mortality, and costs of care in chronic kidney disease. Kidney Int 68:1432–1438PubMedCrossRef Rao M, Pereira BJ (2005) Optimal anemia management reduces cardiovascular morbidity, mortality, and costs of care in chronic kidney disease. Kidney Int 68:1432–1438PubMedCrossRef
4.
Zurück zum Zitat Vasu S, Kelly P, Lawson WE (2005) Anemia in heart failure-a concise review. Clin Cardiol 28:454–458PubMedCrossRef Vasu S, Kelly P, Lawson WE (2005) Anemia in heart failure-a concise review. Clin Cardiol 28:454–458PubMedCrossRef
5.
Zurück zum Zitat Walsh TS, Lee RJ, Maciver CR, Garrioch M, MacKirdy F, Binning AR, Cole S, McClelland DB, for the Audit of Transfusion in Intensive Care in Scotland (ATICS) study group (2006) Anaemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med 32:100–109PubMedCrossRef Walsh TS, Lee RJ, Maciver CR, Garrioch M, MacKirdy F, Binning AR, Cole S, McClelland DB, for the Audit of Transfusion in Intensive Care in Scotland (ATICS) study group (2006) Anaemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med 32:100–109PubMedCrossRef
6.
Zurück zum Zitat Saleh E, McArdle F, Lee RJ, McClleland DBL, Walsh TS (2003) Prevalence of anaemia among survivors of critical illness managed with conservative transfusion triggers: a single centre cohort study. Br J Anaesth 90:819P Saleh E, McArdle F, Lee RJ, McClleland DBL, Walsh TS (2003) Prevalence of anaemia among survivors of critical illness managed with conservative transfusion triggers: a single centre cohort study. Br J Anaesth 90:819P
7.
Zurück zum Zitat Saleh E, McClleland DBL, Walsh TS (2003) How prevalent is anaemia after ICU discharge: a prospective single centre cohort study? Intensive Care Med 29:S34 Saleh E, McClleland DBL, Walsh TS (2003) How prevalent is anaemia after ICU discharge: a prospective single centre cohort study? Intensive Care Med 29:S34
8.
Zurück zum Zitat Chohan SS, McArdle F, McClelland DB, Mackenzie SJ, Walsh TS (2003) Red cell transfusion practice following the Transfusion Requirements in Critical Care (TRICC) study: prospective observational cohort study in a large UK intensive care unit. Vox Sang 84:211–218PubMedCrossRef Chohan SS, McArdle F, McClelland DB, Mackenzie SJ, Walsh TS (2003) Red cell transfusion practice following the Transfusion Requirements in Critical Care (TRICC) study: prospective observational cohort study in a large UK intensive care unit. Vox Sang 84:211–218PubMedCrossRef
9.
Zurück zum Zitat Walsh TS, Garrioch M, Maciver C, Lee RJ, MacKirdy F, McClelland DB, Kinsella J, Wallis C (2004) Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion 44:1405–1411PubMedCrossRef Walsh TS, Garrioch M, Maciver C, Lee RJ, MacKirdy F, McClelland DB, Kinsella J, Wallis C (2004) Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion 44:1405–1411PubMedCrossRef
10.
Zurück zum Zitat Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ (2004) The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 32:39–52PubMedCrossRef Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ (2004) The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 32:39–52PubMedCrossRef
11.
Zurück zum Zitat Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D (2002) Anemia and blood transfusion in critically ill patients. JAMA 288:1499–1507PubMedCrossRef Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D (2002) Anemia and blood transfusion in critically ill patients. JAMA 288:1499–1507PubMedCrossRef
12.
Zurück zum Zitat Pippard MJ, Hoffbrand AV (1990) Iron. In: Hoffbrand AV, Lewis SM (eds) Postgraduate haematology, 3rd edn. Heinemann, Oxford, pp 26–54 Pippard MJ, Hoffbrand AV (1990) Iron. In: Hoffbrand AV, Lewis SM (eds) Postgraduate haematology, 3rd edn. Heinemann, Oxford, pp 26–54
13.
Zurück zum Zitat Goodnough LT, Skikne B, Brugnara C (2000) Erythropoietin, iron, and erythropoiesis. Blood 96:823–833PubMed Goodnough LT, Skikne B, Brugnara C (2000) Erythropoietin, iron, and erythropoiesis. Blood 96:823–833PubMed
14.
Zurück zum Zitat Bellamy MC, Gedney JA (1998) Unrecognised iron deficiency in critical illness. Lancet 352:1903PubMedCrossRef Bellamy MC, Gedney JA (1998) Unrecognised iron deficiency in critical illness. Lancet 352:1903PubMedCrossRef
15.
Zurück zum Zitat Patteril MV, Davey-Quinn AP, Gedney JA, Murdoch SD, Bellamy MC (2001) Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesth Intensive Care 29:473–478PubMed Patteril MV, Davey-Quinn AP, Gedney JA, Murdoch SD, Bellamy MC (2001) Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesth Intensive Care 29:473–478PubMed
16.
Zurück zum Zitat Piagnerelli M, Boudjeltia KZ, Brohee D, Piro P, Carlier E, Vincent JL, Lejeune P, Vanhaeverbeek M (2003) Alterations of red blood cell shape and sialic acid membrane content in septic patients. Crit Care Med 31:2156–2162PubMedCrossRef Piagnerelli M, Boudjeltia KZ, Brohee D, Piro P, Carlier E, Vincent JL, Lejeune P, Vanhaeverbeek M (2003) Alterations of red blood cell shape and sialic acid membrane content in septic patients. Crit Care Med 31:2156–2162PubMedCrossRef
17.
Zurück zum Zitat Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Melot C, Vincent JL (1997) Erythropoietin response is blunted in critically ill patients. Intensive Care Med 23:159–162PubMedCrossRef Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Melot C, Vincent JL (1997) Erythropoietin response is blunted in critically ill patients. Intensive Care Med 23:159–162PubMedCrossRef
18.
Zurück zum Zitat Krafte-Jacobs B (1997) Anemia of critical illness and erythropoietin deficiency. Intensive Care Med 23:137–138PubMedCrossRef Krafte-Jacobs B (1997) Anemia of critical illness and erythropoietin deficiency. Intensive Care Med 23:137–138PubMedCrossRef
19.
Zurück zum Zitat Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG (2001) Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 16:36–41PubMedCrossRef Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG (2001) Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 16:36–41PubMedCrossRef
20.
Zurück zum Zitat Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288:2827–2835PubMedCrossRef Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288:2827–2835PubMedCrossRef
Metadaten
Titel
The prevalence and characteristics of anaemia at discharge home after intensive care
verfasst von
Timothy S. Walsh
Ezz-el-din Saleh
Robert J. Lee
D. Brian McClelland
Publikationsdatum
01.08.2006
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 8/2006
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-006-0213-7

Weitere Artikel der Ausgabe 8/2006

Intensive Care Medicine 8/2006 Zur Ausgabe

Announcements

Announcements

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.